Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
fludrocortisone acetate
×
30 days
×
Clear all
Filters
3
NCT06136650
2026-03-09
MK-5684-004
Merck Sharp & Dohme LLC
Phase 3
Recruiting
1,314 enrolled
NCT06104449
2026-03-06
MK-5684-005
Merck Sharp & Dohme LLC
Phase 1
Active not recruiting
6 enrolled